RxDoctor Payments Data

Ronald Jones, MD

Clinical Cardiac Electrophysiology · Prescott, AZNPI 1255541876

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,810 of the $17,019 with a category attached, or 63.5%. 16 manufacturers reported payments, led by Abbott at 28.4% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in AZ, where the typical reported total is $29,180.

$17,019in general payments, 2019–2025

Across 243 payments — averaging $70.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Boston Scientific$5K
  • Medtronic$4K
  • Biosense Webster, Inc.$2K
  • Atricure, Inc.$615
  • Biotronik Inc.$424
  • plus $392 from 10 others

What the payments were for

  • Travel & lodging$6,20936%
  • Food & beverage$10,81064%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,019 in reported general payments places this provider in the 35th percentile of 80 clinical cardiac electrophysiology providers in Arizona.

See all clinical cardiac electrophysiology providers in Arizona

Medicare billing

Part B allowed, 2024
$299,407
Medicare patients
854
Services billed
3,497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban316$394,040
XareltoRivaroxaban155$181,538
MultaqDronedarone Hcl17$24,337
EntrestoSacubitril/Valsartan19$23,062
Flecainide Acetate106$5,832
Propafenone Hcl ErPropafenone Hcl16$4,526
Metoprolol Succinate209$3,583
Propafenone Hcl17$2,182
Droxidopa11$1,907
Diltiazem 24hr Er (Cd)Diltiazem Hcl59$1,379
Cartia XtDiltiazem Hcl26$782
Amiodarone Hcl42$777
Propranolol Hcl ErPropranolol Hcl17$764
Diltiazem 24hr ErDiltiazem Hcl14$681
Potassium Chloride24$633

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$37$181,538155 claims
NovartisEntresto$12$23,06219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 80 clinical cardiac electrophysiology providers in Arizona.

Other clinical cardiac electrophysiology in Prescott

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →